Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name KCNQ1OT1
   Synonyms KCNQ1OT1, KCNQ1-AS2, Kncq1, KvDMR1, KvLQT1-AS, LIT1, NCRNA00012
   Region GRCh38_11:2608328-2699994    Sequence
   Ensembl ENSG00000269821
   RefSeq NR_002728
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name hepatocellular carcinoma
   ICD-0-3 C22.0  M8170/3
   Methods qPCR, Luciferase reporter assay, Western blot, etc.
   Sample HCC cell lines (SMMC-7721, Huh7, SK-Hep-1 , HepG2). normal liver cell lines (Lo-2).
   Expression Pattern up-regulated
   Function Description

Results showed that KCNQ1OT1 was significantly up-regulated in oxaliplatin-resistant HepG2 and Huh7 cells. Moreover, knockdown of KCNQ1OT1 inhibited the cell proliferation, migration, invasion and reduced the expression of drugresistant gene (MRP5, MDR1, LRP1). Cell survival rate of HCC cells was determined with an increasing concentration of OXA. As shown in Fig. 1C, HepG2/OXA and Huh7/OXA cells exhibited a higher cell survival rate, compared with parental HepG2 and Huh7 cells. Conclusively, KCNQ1OT1 modulated oxaliplatin resistance in hepatocellular carcinoma through miR-7-5p/ABCC1 axis,indicating a novel approach for the treatment of hepatocellular carcinoma.

   Pubmed ID 29966655
   Year 2018
   Title Long non-coding RNA KCNQ1OT1 modulates oxaliplatin resistance in hepatocellular carcinoma through miR-7-5p/ ABCC1 axis.
   External Links
   Links for  KCNQ1OT1 GenBank       HGNC       lncrnadb       Noncode
   Links for  hepatocellular carcinoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.